Buy, Sell or Hold: Cangene Corp (CNJ-T) — Stock Predictions at Stockchase

skip to content

Home Daily Stock Opinions and Ratings Cangene Corp (CNJ-T)

0.00

0.00 (0.00%) 1d

BUY

He bought more today. Shares are hitting new highs. He sold JNJ and bought this. He won't trade it, but hold for 10 years and will keep buying. Revenues were up 22% and 25% on sales. 10 of their drugs have double-digit earnings growth. Great dividend growth.

biotechnology / pharmaceutical

DON'T BUY

Great balance sheet but company is at the US government’s mercy. Will make money but over a longer period of time. He is not a big fan of this story because there are a lot better opportunities out there right now.

biotechnology / pharmaceutical

PAST TOP PICK

(Top Pick Nov 11/10, Down 42.22%) Revenues are down. Major positive is a new CEO with a good track record came on a while ago. This company could be sold in a take-over, perhaps.

biotechnology / pharmaceutical

PAST TOP PICK

(A Top Pick Nov 11/10. Down 51.45%.) Sold his personal holdings at $3.18. Recently have had some good news. The new CEO has a good track record and a lot of potential. Lots of cash and a good balance sheet but they don't have enough products to sell.

biotechnology / pharmaceutical

PAST TOP PICK

(Top Pick Nov 11/10, Down 56.50%) He got out of it personally but fund has it. Heard quarterly numbers were going to be bad and didn’t see it turning around for quite a while. New CEO that came on in August has quite a track record.

biotechnology / pharmaceutical

WAIT

On the buy list (his partner’s). The CEO was booted out a little while ago. Company had problems because of major product in the states. It is going to spread out revenues over time. Moves sales force in-house. Need economies of scale to boost the bottom line. He says he would wait for it to go a little higher.

biotechnology / pharmaceutical

HOLD

Undergoing tremendous changes. Looking for new products. They are looking to make an acquisition to expand product line.

biotechnology / pharmaceutical

BUY

A Contrarian pick in the pharma sector. Did well post-911 when people were bulking up on certain drugs. Management was a little optimistic about how well they could replace those drugs in the pipeline. He would expect it to suddenly jump out of the box.

biotechnology / pharmaceutical

DON'T BUY

Would recommend that you stay away from this one because there is no predictability from year to year on their earnings.

biotechnology / pharmaceutical

TOP PICK

Some risks as revenues have gone down year to year from $240 million to $160 million. Marginal in terms of profitability from $60 million to $8 million. Has been profitable for most of the past 8 years. Good management and no debt and over $40 million in cash.

biotechnology / pharmaceutical

HOLD

Past pick. 13% increase... doing well. Be content to hold.

biotechnology / pharmaceutical

TOP PICK

Good earnings/revenues.

biotechnology / pharmaceutical

Showing 1 to 12 of 12 entries

«
‹
1
›
»

Cangene Corp(CNJ-T) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 1

Stockchase rating for Cangene Corp is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Cangene Corp(CNJ-T) Frequently Asked Questions

What is Cangene Corp stock symbol?

Cangene Corp is a OTC stock, trading under the symbol CNJ-T on the (). It is usually referred to as or CNJ-T

Is Cangene Corp a buy or a sell?

In the last year, 1 stock analyst published opinions about CNJ-T. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Cangene Corp.

Is Cangene Corp a good investment or a top pick?

Cangene Corp was recommended as a Top Pick by on . Read the latest stock experts ratings for Cangene Corp.

Why is Cangene Corp stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Cangene Corp worth watching?

1 stock analyst on Stockchase covered Cangene Corp In the last year. It is a trending stock that is worth watching.

What is Cangene Corp stock price?

On , Cangene Corp (CNJ-T) stock closed at a price of $.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

© Stockchase Inc.